is jardiance a glp-1 receptor agonist Closer Look at the Dermatological Profile of Agonists Medication Options for Type 2

Health Canada Details DIN Checks, CBSA Role in GLP-1 Advisory Health Canada's public advisory on unauthorized and counterfeit GLP-1 receptor agonist products, last updated January 21, 2026, instructs Canadians to verify any prescription product by checking for an eight-digit Drug Identification Number (DIN) on the label and searching Health Canada's Drug Product Database before purchase [Source: recalls-rappels.canada.ca/en/alert-recall/thinking-about-buying-glp-1-drugs-ozempic-or-mounjaro-beware-fake-or-unauthorized]

So they are not recommended for people who have had pancreatitis

Long-term clinical outcomes regarding body weight reduction and cardiovascular outcomes are to be investigated

GIPR increases insulin secretion during hyperglycemia and stimulates glucagon release during hypoglycemia

Sources: Hedgman, A

doi: 10.1007/s11892-007-0056-9 [DOI] [PubMed] [Google Scholar] 120